Divya Joykutty
Primary Care · Oklahoma City, OKNPI 1336370113
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,428 and has fallen 91.3% since, to $124 in 2025. Among primary care clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$564
- AbbVie$330
- AstraZeneca$330
- GSK$265
- Lilly USA, LLC$232
- Pfizer$205
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 48 | $564 |
| AbbVie | 23 | $330 |
| AstraZeneca(2 entities) | 15 | $330 |
| GSK | 14 | $265 |
| Lilly USA, LLC | 18 | $232 |
| Pfizer | 11 | $205 |
| Boehringer Ingelheim | 13 | $180 |
| Abbott | 10 | $154 |
| Astellas Pharma US Inc | 7 | $124 |
| Amgen(2 entities) | 8 | $112 |
| Sanofi-aventis U.S. LLC | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Merck | 4 | $55 |
| Bayer | 3 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Amarin Pharma, Inc. | 2 | $35 |
| Scilex Pharmaceuticals Inc. | 2 | $34 |
| Dynavax Technologies Corporation | 2 | $31 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| SK Life Science, Inc. | 1 | $27 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Upsher-smith Laboratories LLC | 1 | $17 |
| Scynexis, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Corium, LLC | 1 | $13 |
| Sunovion Pharmaceuticals Inc. | 1 | $13 |
| Genentech USA, Inc. | 2 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,122 in reported general payments places this provider in the 90th percentile of 83 primary care providers in Oklahoma.
Other primary care in Oklahoma City
- Misty DeanOklahoma City$6K
- Jessica KearneyOklahoma City$5K
- Erin OlmstedOklahoma City$3K
- Kathy SpeigelOklahoma City$1K
- Kimberly AllenOklahoma City$1K
- Mandi BrownOklahoma City$978
- Thomas CookOklahoma City$792
- Krystal RachalOklahoma City$704
- Kendra BondOklahoma City$488
- Janice GuthrieOklahoma City$220
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.